Clinical Trial Update: Topotecan in Treating Children With Refractory Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating Topotecan in children with refractory leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• Topotecan (topotecan)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Leukemia | Phase 1 | Status: COMPLETED